colistimethate sodium has been researched along with Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altay, A; Buttini, F; Colombo, G; Kozáková, J; Mašková, L; Quarta, E; Rossi, A; Sonvico, F; Ždímal, V | 1 |
1 other study(ies) available for colistimethate sodium and Infections
| Article | Year |
|---|---|
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction.
Topics: Administration, Inhalation; Aerosols; Colistin; Cystic Fibrosis; Drug Compounding; Dry Powder Inhalers; Humans; Infections; Lung; Particle Size; Powders; Solvents | 2019 |